Modified FOLFIRINOX

Phase 2

00%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

10mo

EXASPhase 2$7.7B

Modified FOLFIRINOX Phase 2 Results Expected

Modified FOLFIRINOX• Locally Advanced Pancreatic Adenocarcinoma25

Dec 15Estimated

00%

Competitive Landscape

0 competitors in Locally Advanced Pancreatic Adenocarcinoma

Drug Information

Target Indication

Locally Advanced Pancreatic Adenocarcinoma

Clinical Trial

Last updated: 1/11/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

EXAS

EXACT SCIENCES CORP